An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology

Archives of Pathology and Laboratory Medicine

Volumn 132, Issue 8, 2008, Pages 1285-1289

  Chetty, Runjan ^a,b  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; TUMOR MARKER;

CHROMOSOMAL INSTABILITY; CPG ISLAND; GASTROINTESTINAL TRACT; GASTROINTESTINAL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NEUROSECRETORY CELL; PANCREAS TUMOR; REVIEW; SYNDROME DELINEATION; TUMOR CLASSIFICATION; TUMOR DIAGNOSIS; WORLD HEALTH ORGANIZATION;

GASTROINTESTINAL NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; TERMINOLOGY AS TOPIC; TUMOR MARKERS, BIOLOGICAL;

EID: 49349140798     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Oberndorfer S. Karzinoide tumoren des Dunndarms. Frankf Z Pathol. 1907;1:425-432.
2. Kloppel G, Perren A, Heitz PU. The gastroenteropancreatic neuroendocrine cell system and its tumors: the WHO classification. Ann N Y Acad Sci. 2004;1014:13-27.
3. Rindi G. Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours: introduction. Neuroendocrinology. 2004;80:395.
4. Wick MR. Neuroendocrine neoplasia: current concepts. Am J Clin Pathol. 2000;113:331-335.
5. Solcia E, Klöppel G, Sobin LH, et al. Histological Typing of Endocrine Tumours. 2nd ed. Berlin, Germany: Springer; 2000. World Health Organization International Histological Classification of Tumours.
6. Rindi G, Kloppel G. Endocrine tumors of the gut and pancreas: tumor biology and classification. Neuroendocrinology. 2004;80(suppl 1):12-15.
7. Rindi G, Kloppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395-401.
8. Rindi G, Kloppel G, Couvelard A, et al. TNM staging of midgut and hindgut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2007;451:757-762.
9. Srivastava A, Padilla O, Fischer-Colbrie R, Tischler AS, Dayal Y. Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids. Am J Surg Pathol. 2004;28:1371-1378.
10. Papotti M, Cassoni P, Volante M, et al. Ghrelin-producing endocrine tumors of the stomach and intestine. J Clin Endocrinol Metab. 2001;86:5052-5059.
11. Kulaksiz H, Eissele R, Rossler D, et al. Identification of somatostatin receptor subtypes 1, 2A, 3 and 5 in neuroendocrine tumours with subtype specific antibodies. Gut. 2002;50:52-60.
12. Papotti M, Bongiovanni M, Volante M, et al. Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors: a correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Arch. 2002;440:461-475.
13. Tanimoto A, Matsuki Y, Tomita T, et al. Histidine decarboxylase expression in pancreatic endocrine cells and related tumors. Pathol Int. 2004;54:408-412.
14. Feurle GE, Anlauk M, Hamscher G, et al. Xenin-immunoreactive cells and extractable xenin in neuroendocrine tumors of the duodenal origin. Gastroenterology. 2002;123:1616-1626.
15. Schmitt A, Anlauf M, Rousson V, et al. WHO 2004 criteria and CK19 are reliable prognostic markers in pancreatic endocrine tumors. Am J Surg Pathol. 2007;31:1677-1682.
16. Grotzinger C. Tumour biology of gastroenteropancreatic neuroendocrine tumors. Neuroendocrinology. 2004;80(suppl 1):8-11.
17. Perren A, Anlauf M, Komminoth P. Molecular profiles of gastroenteropancreatic endocrine tumors. Virchows Arch. 2007;451(suppl 1):S39-S46.